Table 2 Baseline characteristics of participants by hyperuricemia status
Character | Total group n = 4855 | Hyperuricemic | p | |
|---|---|---|---|---|
NO n = 3918 (80.7) | YES n = 937 (19.3) | |||
Age, n (%) |  |  |  |  < 0.01 |
 18–40 years | 1024 (21.1) | 766 (74.8) | 258 (25.2) |  |
 40–65 years | 1879 (38.7) | 1529 (81.4) | 350 (18.6) |  |
 ≥ 65 years | 1952 (40.2) | 1623 (83.1) | 329 (16.9) |  |
Gender, n (%) |  |  |  |  < 0.01 |
 Men | 2019 (41.6) | 1574 (78.0) | 445 (22.0) |  |
 Woman | 2836 (58.4) | 2344 (82.7) | 492 (17.3) |  |
Residence, n (%) |  |  |  |  < 0.01 |
 Urban | 1869 (38.5) | 1415 (75.7) | 454 (24.3) |  |
 Rural | 2986 (61.5) | 2503 (83.8) | 483 (16.2) |  |
Education, n (%) | Â | Â | Â | Â |
 Low | 2271 (46.8) | 1910 (84.1) | 361 (15.9) |  < 0.01 |
 Middle | 2078 (42.8) | 1633 (78.6) | 375 (21.4) |  |
 High | 506 (10.4) | 375 (74.1) | 131 (25.9) |  |
Current smoker, n (%) | Â | Â | Â | 0.46 |
 Yes | 966 (19.9) | 778 (80.5) | 188 (19.5) |  |
 No | 3889 (80.1) | 3140 (80.7) | 749 (19.3) |  |
Recent drink, n (%) | Â | Â | Â | Â |
 Yes | 840 (17.3) | 623 (74.2) | 217 (25.8) |  < 0.01 |
 No | 4015 (82.7) | 3295 (82.1) | 720 (17.9) |  |
BMI ≥ 24.0, n (%) |  |  |  |  < 0.01 |
 Yes | 2834 (58.4) | 2131 (75.2) | 703 (24.8) |  |
 No | 2021 (41.6) | 1787 (88.4) | 234 (11.6) |  |
Hypertension, n (%) |  |  |  |  < 0.01 |
 Yes | 2561 (52.7) | 2008 (78.4) | 553 (21.6) |  |
 No | 2294 (17.3) | 1910 (83.3) | 384 (16.7) |  |
Diabetes, n (%) | Â | Â | Â | 0.81 |
 Yes | 602 (12.4) | 488 (81.1) | 114 (18.9) |  |
 No | 4253 (87.6) | 3430 (80.6) | 823 (19.4) |  |
TC (mmol/L), (SD) | 4.66 ± 0.99 | 4.62 ± 0.97 | 4.83 ± 1.08 |  < 0.01 |
HDL-C (mmol/L), (SD) | 1.29 ± 0.36 | 1.32 ± 0.35 | 1.17 ± 0.34 |  < 0.01 |
LDL-C (mmol/L), (SD) | 2.84 ± 0.91 | 2.83 ± 0.88 | 2.90 ± 1.00 |  < 0.01 |
TG (mmol/L), (SD) | 1.70 ± 1.66 | 1.58 ± 1.25 | 2.18 ± 1.86 |  < 0.01 |
Dyslipidemia, n (%) |  |  |  |  < 0.01 |
 Yes | 1623 (33.4) | 1156 (29.5) | 467 (49.8) |  |
 No | 3323 (66.6) | 2762 (70.5) | 470 (50.2) |  |